Overview
- Large cohort analyses show regular, moderate coffee—especially paper-filtered brews—is associated with lower rates of liver disease, reduced inflammation, and lower cardiovascular mortality compared with no coffee or unfiltered coffee.
- A 2026 small clinical study found medical students drinking one to two cups daily scored higher on exams than those who drank none or three-plus cups, which suggests modest intake can boost short-term cognitive performance.
- A separate 2026 clinical withdrawal trial reported that abrupt 24-hour caffeine cessation in office workers produced near-universal fatigue, widespread drops in motivation and attention, mood swings, and frequent headaches, showing rapid dependence effects.
- The preparation method matters because paper filters trap diterpenes such as cafestol and kahweol that raise cholesterol; unfiltered methods like French press and espresso deliver far higher amounts of those compounds.
- Official guidance and limits anchor the findings: EFSA notes about 75 mg of caffeine (roughly one cup) produces measurable cognitive effects and German federal advice sets about 400 mg per day as an upper intake for most adults, while researchers warn that cohort studies are observational and clinical samples remain small.